Xia Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial.
Journal: Nature communications
Published: September 18, 2025
IL-2 detected by flow cytometry and its significance in systemic lupus erythematosus.
Journal: Clinical rheumatology
Published: November 21, 2024
Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis.
Journal: Arthritis research & therapy
Published: June 25, 2024
Study of 43 SLE patients with autoimmune liver cirrhosis: emphasis on clinical features and differences from lupus without cirrhosis.
Journal: International journal of rheumatic diseases
Published: September 21, 2022
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Journal: Lupus science & medicine
Published: July 10, 2022
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis.
Journal: Rheumatology and therapy
Published: August 03, 2021
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.
Journal: PLoS pathogens
Published: April 21, 2021
Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission.
Journal: Frontiers in medicine
Published: October 24, 2019
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
Journal: Annals of the rheumatic diseases
Published: March 17, 2019
Interleukin-2 Deficiency Associated with Renal Impairment in Systemic Lupus Erythematosus.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: February 06, 2019
Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus.
Journal: Chinese medical journal
Published: June 27, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026